The Technical Analyst
Select Language :
Photocure ASA [PHO.OL]

Exchange: OSE Sector: Pharmaceuticals Industry: Drug Manufacturers—Specialty & Generic

Photocure ASA Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Photocure ASA is listed at the  Exchange

-0.90% NOK55.00

Europe/Oslo / 27 mar 2024 @ 13:05


FUNDAMENTALS
MarketCap: 1 490.81 mill
EPS: -1.240
P/E: -44.35
Earnings Date: May 15, 2024
SharesOutstanding: 27.11 mill
Avg Daily Volume: 0.0857 mill
RATING 2024-03-27
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -44.35 | sector: PE -43.24
PE RATIO: COMPANY / INDUSTRY
-0.27x
Company: PE -44.35 | industry: PE 165.19
DISCOUNTED CASH FLOW VALUE
NOK37.61
(-31.61%) NOK-17.39
Date: 2024-03-28
Expected Trading Range (DAY)

NOK 52.67 - 57.33

( +/- 4.24%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 13:15 - NOK55.00
Forecast 2: 14:05 - NOK55.00
Forecast 3: 14:45 - NOK55.00
SCORE
-8.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price NOK55.00 (-0.90% )
Volume 0.0400 mill
Avg. Vol. 0.0857 mill
% of Avg. Vol 46.73 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Photocure ASA

Last 12 Months

Last 12 months chart data with high, low, open and close for Photocure ASA

RSI

Intraday RSI14 chart for Photocure ASA

Last 10 Buy & Sell Signals For PHO.OL

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:38sellNOK61.10N/AActive
Profile picture for
            Photocure ASA

PHO.OL

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Last 10 Buy Signals

Date Signal @
RBTCUSDMar 28 - 13:13$69 850
KUJIUSDMar 28 - 13:132.82
EGXUSDMar 28 - 13:14199.67
AGIUSDMar 28 - 13:130.448
FRAXUSDMar 28 - 13:10$0.996
BOBAUSDMar 28 - 13:080.609
ROUTEUSDMar 28 - 13:053.95
PROUSDMar 28 - 12:58$2.25
ALPHUSDMar 28 - 12:572.78
GALXUSDMar 28 - 12:535.16

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.